It is with deep sorrow that we learned of the passing of Edda Gomez-Panzani, MD on June 30, 2015. The NorCal CarciNET Community shared a tribute to Edda who “was instrumental in gaining FDA approval for Somatuline (lanreotide) for NETs patients in December 2014.” This wonderful picture of Edda was taken by her dear friend, the late Monica Warner.
Dr. Gomez-Panzani, Vice President of Research & Scientific Affairs for Ipsen Biopharmaceuticals, died from cancer at her home in California, surrounded by loved ones. Click here to read her obituary.
The neuroendocrine tumor (NET) community has lost a very special friend and advocate. All of us at the Carcinoid Cancer Foundation extend our deepest sympathies to Edda’s family, friends, and colleagues.